Pigmented progressive purpuric dermatosis - Dermatożi Purpurika Progressiva Pigmentatahttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Dermatożi Purpurika Progressiva Pigmentata (Pigmented progressive purpuric dermatosis) tirreferi għall-kundizzjonijiet tal-ġilda mingħajr ħakk ikkaratterizzati minn eruzzjonijiet purpuriċi tal-ġilda. Id-daqs tal-leżjoni huwa minn 0.3 sa 1 ċm u ħafna drabi jidhru fl-estremitajiet t'isfel. Il-krema tal-kortisone tgħin għall-ħakk u ttejjeb il-kulur tal-ġilda. dermatożi purpurika progressiva pigmentata (pigmented progressive purpuric dermatosis) ma tikkawża l-ebda sintomi oħra minbarra tibdil fil-kulur tal-ġilda. Il-leżjonijiet huma l-aktar frekwenti fuq ir-riġlejn t'isfel, iżda jistgħu jseħħu kullimkien fuq il-ġisem, inklużi l-idejn, id-dirgħajn, it-torso u anke l-għonq.

Trattament - Drogi OTC
Ingwent sterojdi OTC
#Hydrocortisone ointment
#Hydrocortisone cream
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
  • Schamberg disease ― raġel ta’ 26 sena b’roqgħa ta’ pigmentazzjoni bla sintomi u telangiectasia fuq is-sieq.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Pigmented purpuric dermatoses (PPD) huma grupp ta’ kundizzjonijiet tal-ġilda mmarkati minn żoni żgħar ta’ fsada taħt il-ġilda minħabba infjammazzjoni kapillari. PPD tipikament jibdew bħala tikek ħomor għal vjola li aktar tard isiru kannella dehbi hekk kif l-emosiderin jiġi assorbit mill-ġdid.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease huwa l-aktar tip komuni ta ' pigmented purpuric dermatoses (PPDs) , li huma kundizzjonijiet kroniċi tal-ġilda kkaratterizzati minn tikek ħomor jew vjola żgħar, u żieda fil-kulur tal-ġilda (garża ta' kannella, aħmar jew isfar) . PPDs huma kklassifikati f'ħames tipi: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Schamberg disease (SD) hija magħrufa wkoll bħala progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressiva, Schamberg's purpura. Taffettwa prinċipalment l-irġiel u tipikament tidher fuq ir-riġlejn t'isfel, iżda tista 'sseħħ ukoll fuq il-koxox, il-warrani, it-tronk, jew l-armi.
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    Ġiet analizzata informazzjoni dwar 113-il pazjent b'PPD, inklużi 38 li għaddew minn bijopsija tal-ġilda għal dan l-istudju. L-aktar tip kliniku komuni kienet il-marda ta' Schamberg (60. 5%) . Kundizzjonijiet oħra flimkien mal-PPD kienu pressjoni għolja (15. 8%) , dijabete (10. 5%) , u oħrajn. L-istorja tal-medikazzjoni wrew statins (13. 2%) , beta blockers (10. 5%) , u oħrajn. Fatturi possibbli marbuta ma 'PPD kienu jinkludu infezzjoni reċenti tan-nifs ta' fuq (5. 3%) , waqfien fit-tul li jwassal għal pressjoni ortostatika għolja (2. 6%) , u eżerċizzju qawwi (2. 6%) . It-trattament ingħata lil 36 pazjent (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.